Sign Up to like & get
recommendations!
2
Published in 2023 at "Drug Development Research"
DOI: 10.1002/ddr.22042
Abstract: A series of imidazodiazepines has been developed that possess reduced sedative liabilities but retain efficacy in anticonvulsant screening models. The latest of these compounds, (5‐(8‐ethynyl‐6‐(pyridin‐2‐yl)‐4H‐benzo[f]imidazole[1,5‐α][1,4]diazepin‐3‐yl) oxazole known as KRM‐II‐81) is currently awaiting advancement into the…
read more here.
Keywords:
comparative anticonvulsant;
krm;
anticonvulsant activity;
anticonvulsant ... See more keywords